272 related articles for article (PubMed ID: 16525186)
1. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors.
Meyers CA; Brown PD
J Clin Oncol; 2006 Mar; 24(8):1305-9. PubMed ID: 16525186
[TBL] [Abstract][Full Text] [Related]
2. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature.
Weitzner MA; Meyers CA
Psychooncology; 1997 Sep; 6(3):169-77. PubMed ID: 9313282
[TBL] [Abstract][Full Text] [Related]
3. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.
Abrey LE; Batchelor TT; Ferreri AJ; Gospodarowicz M; Pulczynski EJ; Zucca E; Smith JR; Korfel A; Soussain C; DeAngelis LM; Neuwelt EA; O'Neill BP; Thiel E; Shenkier T; Graus F; van den Bent M; Seymour JF; Poortmans P; Armitage JO; Cavalli F;
J Clin Oncol; 2005 Aug; 23(22):5034-43. PubMed ID: 15955902
[TBL] [Abstract][Full Text] [Related]
4. Pediatric CNS tumors: current treatment and future directions.
Hargrave DR; Zacharoulis S
Expert Rev Neurother; 2007 Aug; 7(8):1029-42. PubMed ID: 17678498
[TBL] [Abstract][Full Text] [Related]
5. The course of neurocognitive functioning in high-grade glioma patients.
Bosma I; Vos MJ; Heimans JJ; Taphoorn MJ; Aaronson NK; Postma TJ; van der Ploeg HM; Muller M; Vandertop WP; Slotman BJ; Klein M
Neuro Oncol; 2007 Jan; 9(1):53-62. PubMed ID: 17018697
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
Corn BW; Moughan J; Knisely JP; Fox SW; Chakravarti A; Yung WK; Curran WJ; Robins HI; Brachman DG; Henderson RH; Mehta MP; Movsas B
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):71-8. PubMed ID: 18164829
[TBL] [Abstract][Full Text] [Related]
7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
8. Novel radiosensitizers for tumors of the central nervous system.
Mehta MP; Suh JH
Curr Opin Investig Drugs; 2004 Dec; 5(12):1284-91. PubMed ID: 15648950
[TBL] [Abstract][Full Text] [Related]
9. Current treatment approaches for infants with malignant central nervous system tumors.
Lafay-Cousin L; Strother D
Oncologist; 2009 Apr; 14(4):433-44. PubMed ID: 19342475
[TBL] [Abstract][Full Text] [Related]
10. Survival and late mortality in long-term survivors of pediatric CNS tumors.
Morris EB; Gajjar A; Okuma JO; Yasui Y; Wallace D; Kun LE; Merchant TE; Fouladi M; Broniscer A; Robison LL; Hudson MM
J Clin Oncol; 2007 Apr; 25(12):1532-8. PubMed ID: 17442996
[TBL] [Abstract][Full Text] [Related]
11. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
12. No improvement in neurocognitive outcomes after off-pump versus on-pump coronary revascularisation: a meta-analysis.
Marasco SF; Sharwood LN; Abramson MJ
Eur J Cardiothorac Surg; 2008 Jun; 33(6):961-70. PubMed ID: 18424064
[TBL] [Abstract][Full Text] [Related]
13. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
14. CNS tumors: monitoring therapeutic response and outcome prediction.
Cha S
Top Magn Reson Imaging; 2006 Apr; 17(2):63-8. PubMed ID: 17198223
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials referral resource. Current clinical trials in CNS tumors.
Kaplan RS; Schoenfeldt M
Oncology (Williston Park); 2004 Mar; 18(3):322, 327, 330 passim. PubMed ID: 15065702
[No Abstract] [Full Text] [Related]
16. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.
Gehring K; Sitskoorn MM; Gundy CM; Sikkes SA; Klein M; Postma TJ; van den Bent MJ; Beute GN; Enting RH; Kappelle AC; Boogerd W; Veninga T; Twijnstra A; Boerman DH; Taphoorn MJ; Aaronson NK
J Clin Oncol; 2009 Aug; 27(22):3712-22. PubMed ID: 19470928
[TBL] [Abstract][Full Text] [Related]
17. A study design to assess the safety and efficacy of on-pump versus off-pump coronary bypass grafting: the ROOBY trial.
Novitzky D; Shroyer AL; Collins JF; McDonald GO; Lucke J; Hattler B; Kozora E; Bradham DD; Baltz J; Grover FL;
Clin Trials; 2007; 4(1):81-91. PubMed ID: 17327248
[TBL] [Abstract][Full Text] [Related]
18. Current approaches to CNS tumors in infants and very young children.
Warren KE; Packer RJ
Expert Rev Neurother; 2004 Jul; 4(4):681-90. PubMed ID: 15853587
[TBL] [Abstract][Full Text] [Related]
19. Diffusely infiltrative low-grade gliomas in adults.
Lang FF; Gilbert MR
J Clin Oncol; 2006 Mar; 24(8):1236-45. PubMed ID: 16525178
[TBL] [Abstract][Full Text] [Related]
20. The future of glioma treatment: stem cells, nanotechnology and personalized medicine.
Rahman M; Hoh B; Kohler N; Dunbar EM; Murad GJ
Future Oncol; 2012 Sep; 8(9):1149-56. PubMed ID: 23030489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
